These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6310486)

  • 1. [Intraoperative radiotherapy in combination with misonidazole; with special reference to the drug concentrations in tumors and normal tissues and to the initial effect of the treatment].
    Takahashi M; Ono K; Hamanaka D; Dodo Y; Hiraoka M; Nishidai T; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Mar; 43(3):466-77. PubMed ID: 6310486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences with intraoperative radiotherapy of locally advanced carcinomas].
    Abe M; Takahashi M
    Strahlentherapie; 1982 Oct; 158(10):585-93. PubMed ID: 7179341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peroperative radiotherapy].
    Popowski Y; Piron A; Ewalenko P; Pector JC; Gerard A; Van Houtte P
    Rev Med Brux; 1989; 10(1-2):17-21. PubMed ID: 2928607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin-misonidazole: possible metabolic interaction.
    Gangji D; Schwade JG; Strong JM
    Cancer Treat Rep; 1980 Jan; 64(1):155-6. PubMed ID: 7379050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I.V. misonidazole (NSC 261037). Report of initial clinical experience.
    Schwade JG; Strong JM; Gangji D
    Cancer Clin Trials; 1981; 4(1):33-9. PubMed ID: 7214660
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
    Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P
    Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
    Asakawa H; Watarai J; Hoshino T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraoperative radiotherapy].
    Hata K; Miyoshi M; Uehara S; Shimamura Y; Furusawa M; Tomoda H; Seo Y; Abe M; Hara Y; Jimi S
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1564-9. PubMed ID: 3592700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraoperative radiotherapy in oncology].
    Gérard JP; Calvo F; Braillon G; Dubois JB; Guillemin C; Roussel A; Saint-Aubert B; Sentenac I
    Pathol Biol (Paris); 1992 Nov; 39(9):881-2. PubMed ID: 1538919
    [No Abstract]   [Full Text] [Related]  

  • 11. Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799.
    Dische S; Saunders MI; Dunphy EP; Bennett MH; Des Rochers C; Stratford MR; Minchinton AI; Orchard RA
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1109-11. PubMed ID: 2943708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
    White RA; Workman P; Brown JM
    Radiat Res; 1980 Dec; 84(3):542-61. PubMed ID: 6450431
    [No Abstract]   [Full Text] [Related]  

  • 13. [Radiosensitizing effect of misonidazole in radiotherapy for intracranial tumors].
    Otsuka S
    Nihon Geka Hokan; 1982 Nov; 51(6):892-906. PubMed ID: 7171270
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ; Whitmore GF
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic considerations of misonidazole in therapeutics.
    Matheson I; Plowman PN; Johnston A
    Hum Toxicol; 1984 Feb; 3(1):29-36. PubMed ID: 6698564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
    Akel G; Canal P; Bugat R; Soula G; Combes PF
    J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
    Chin JB; Rauth AM
    Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radiotherapy in combination with misonidazole and ACNU in lung neoplasms].
    Asakura H; Maruhashi A; Mashima Y; Kanazawa A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Nov; 43(11):1295-306. PubMed ID: 6584857
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications and clinical aspects of intraoperative radiation therapy].
    Takahashi M; Shibamoto Y; Abe M
    Rinsho Hoshasen; 1986 Mar; 31(3):397-403. PubMed ID: 3088301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radiotherapy of gastro-intestinal tumours].
    Kärcher KH
    Wien Klin Wochenschr; 1972 Nov; 84(44):705-8. PubMed ID: 4628602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.